Orthogonal engineering of synthetic T cell states to enhance cancer immunotherapy
Nat Immunol
.
2023 May;24(5):733-735.
doi: 10.1038/s41590-023-01470-9.
Authors
Alberto G Conti
1
,
Rahul Roychoudhuri
2
Affiliations
1
Department of Pathology, University of Cambridge, Cambridge, UK. agc53@cam.ac.uk.
2
Department of Pathology, University of Cambridge, Cambridge, UK. rr257@cam.ac.uk.
PMID:
37081149
DOI:
10.1038/s41590-023-01470-9
No abstract available
Publication types
Comment
MeSH terms
Genetic Engineering
Humans
Immunotherapy*
Immunotherapy, Adoptive
Neoplasms* / genetics
Neoplasms* / therapy
T-Lymphocytes